Project Grant R35GM158455
Award Date
6/1/25
Completion Date
4/30/30
Dollars Obligated
$413K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
This $1,675,000 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to understand the mechanisms that regulate different forms of regulated cell death. The award aims to identify how various cell death pathways inhibit and interact with each other, and the therapeutic implications of these interactions. The research team has developed new experimental,...
The National Institute of General Medical Sciences (NIGMS) awarded a $421,600 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the Morgridge Institute for Research, Inc. to investigate the interplay of genetic and environmental factors that influence human cell fitness. The project aims to: 1) understand context-dependent genetic contributions to cell growth, 2) examine physiologic nutrient dependencies, and 3) delineate environmental contributions to T cell fitness....
This Project Grant award from the National Cancer Institute's Cancer Biology Research Program (CFDA 93.396) supports research to investigate the role of panoptosis (a collective term for pyroptosis, apoptosis, and necroptosis) in the treatment of myelodysplastic syndromes (MDS). The $344,111 award to Loyola University of Chicago's Health Sciences Campus, effective April 1, 2025 through March 31, 2030, aims to determine whether genetic or pharmacological inhibition of RIPK1 and TBK1 can restore...
This $379,131 federal Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) aims to accelerate the development of macromolecule-based therapeutics. The primary objectives are to: 1) Establish rapid characterization methods to assess the conformation and dynamics of disordered peptides and peptidomimetics, 2) Develop predictive algorithms to identify sequence spaces favoring desired...
This $1,380,568 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports an interdisciplinary research project at the University of Chicago. The project aims to develop a comprehensive, multiscale understanding of how cells adapt to changes in their environment, which could lead to new therapeutic interventions for diseases related to maladaptive cellular states. The research is...
This $1,470,366 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research at the University of Texas MD Anderson Cancer Center on the noncanonical roles of the BIM protein in heat shock-induced cell death. The project aims to determine: 1) the roles of BIM in regulating lysosome number and positioning; 2) the roles of BIM in heat shock-induced lysosomal membrane permeabilization and...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,675,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of Massachusetts Medical School (UMass Medical) to conduct research on the cell biology of mammalian nuclei. The key research focuses on two areas: 1) understanding how the tumor marker protein Ki-67 protects chromosomes, including mapping its chromatin-binding domains and determining the specific genomic loci that are damaged...
The National Institute of General Medical Sciences (NIGMS) awarded a $541,967 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Chicago. The grant, valid from January 1, 2025 through December 31, 2029, supports research to expand the understanding of adherent cell mechanics and mechanobiology. Key focus areas include investigating the force-sensitive remodeling of cell-cell adhesions and the role it plays in contact inhibition of...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,248,750 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Mayo Clinic Arizona to develop durable cell-based therapies for treating chronic diseases. The goal is to engineer cells that secrete therapeutic proteins and can be grafted into the body as biological "drug factories" to provide long-term cures for conditions like hemophilia, diabetes, and liver disorders. The...
The federal Project Grant award, with ID R35GM156454, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The award, totaling $440,000.00 and granted on February 3, 2025, supports a research program focused on in-depth exploration of the ubiquitin and autophagy pathways, which are essential cellular processes involved in proteome homeostasis or proteostasis. The key objectives of this project are to...